Novartis has a strong presence in Europe. With demographics and socioeconomic developments driving long-term growth in demand for healthcare, Novartis expects its businesses to keep expanding in the coming years, both in the established markets of Western Europe, the US and Japan as well as in many emerging markets.
Novartis Vaccines plant in Marburg, Germany
Novartis Pharmaceutical production in Stein, Switzerland
Novartis Biopharmaceutical production in Huningue, France
Novartis Institutes for BioMedical Research in Horsham, United Kingdom
Novartis Vaccines in Liverpool, United Kingdom
Novartis Vaccines and Diagnostics in Siena, Italy
You may use the multimedia material provided in this section for commercial purposes only in relation to Novartis. These images must not be modified in any way and each item must have the copyright acknowledgement of Novartis AG (© Novartis AG).